SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009485
Filing Date
2024-03-11
Accepted
2024-03-11 08:00:36
Documents
21
Period of Report
2024-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46400
2 ex5-1.htm EX-5.1 24938
3 ex10-1.htm EX-10.1 103980
4 ex5-1_001.jpg GRAPHIC 8662
5 ex5-1_002.jpg GRAPHIC 32097
6 ex5-1_003.jpg GRAPHIC 18768
7 ex5-1_004.jpg GRAPHIC 12206
8 ex5-1_005.jpg GRAPHIC 6354
  Complete submission text file 0001493152-24-009485.txt   483887

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE envb-20240308.xsd EX-101.SCH 3012
10 XBRL LABEL FILE envb-20240308_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE envb-20240308_pre.xml EX-101.PRE 22357
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3621
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 24736580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)